Literature DB >> 6203836

Mechanism of bacterial resistance to complement-mediated killing: inserted C5b-9 correlates with killing for Escherichia coli O111B4 varying in O-antigen capsule and O-polysaccharide coverage of lipid A core oligosaccharide.

K A Joiner, M A Schmetz, R C Goldman, L Leive, M M Frank.   

Abstract

The interaction of C3 and terminal complement components with three isogenic strains of Escherichia coli O111B4 varying in outer membrane and capsule composition was examined. Strains CL99 and 1-1, which possess O-antigen capsule and 74 to 77% coverage of lipid A core oligosaccharide, were sensitive to killing in pooled normal human serum (PNHS) or magnesium ethylene glycoltetraacetic acid PNHS in the presence but not the absence of antibody, although 1-1 contained 35% more lipopolysaccharide than CL99 and was slightly less sensitive to alternative pathway killing. In contrast, strain 1-2 lacks O-antigen capsule but contains 84% coverage and resists serum killing in the presence and absence of antibody in both PNHS and magnesium ethylene glycoltetraacetic acid PNHS. All three strains consumed C3 and C9 when incubated in PNHS, but consumption was most rapid with 1-2, which also bound the largest number of C3 molecules per CFU. Between 15 X 10(3) and 24 X 10(3) molecules of C9 per CFU bound to CL99 and 1-1 during incubation in 10% PNHS or 10% magnesium ethylene glycoltetraacetic acid PNHS, and binding was relatively stable. Binding and release of 3 X 10(3) to 8 X 10(3) molecules of C9 per CFU was observed for strain 1-2. The majority of C9 bound to CL99 and 1-1 in the presence of antibody distributed with the outer membrane after lysis of the organisms in a French press, whereas only 16.1 to 20.1% of C9 was deposited on these organisms in the absence of antibody, and 31.5 to 39.8% of C9 on strain 1-2 with or without antibody sedimented with the outer membrane. Between 4.6 X 10(3) and 5.5 X 10(3) molecules of C9 per CFU remained bound in a salt- and trypsin-resistant form to the outer membrane of organisms that were killed, whereas fewer than 1.4 X 10(3) molecules of C9 per CFU were bound to the outer membrane of organisms not killed by serum. These results indicate that C5b-9 that is bound to the outer membrane of E. coli O111B4 in a form resistant to salt or protease elution correlates with bacterial killing.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6203836      PMCID: PMC263282          DOI: 10.1128/iai.45.1.113-117.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  The sensitivity of smooth and rough gram-negative bacteria to the immune bactericidal reaction.

Authors:  L H Muschel; L J Larsen
Journal:  Proc Soc Exp Biol Med       Date:  1970-01

2.  Analyses of lipopolysaccharides extracted from penicillin-resistant, serum-sensitive salmonella mutants.

Authors:  B W Nelson; R J Roantree
Journal:  J Gen Microbiol       Date:  1967-08

3.  The terminal membrane C5b-9 complex of human complement. Evidence for the existence of multiple protease-resistant polypeptides that form the trans-membrane complement channel.

Authors:  S Bhakdi; J Tranum-Jensen; O Klump
Journal:  J Immunol       Date:  1980-05       Impact factor: 5.422

4.  Release of phospholipids from complement-mediated lesions on the surface structure of Escherichia coli.

Authors:  K Inoue; T Kinoshita; M Okada; Y Akiyama
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

5.  Sensitivity of rough gram-negative bacteria to the bactericidal action of serum.

Authors:  D Rowley
Journal:  J Bacteriol       Date:  1968-05       Impact factor: 3.490

6.  Large scale isolation of functionally active components of the human complement system.

Authors:  C H Hammer; G H Wirtz; L Renfer; H D Gresham; B F Tack
Journal:  J Biol Chem       Date:  1981-04-25       Impact factor: 5.157

7.  Plasmid-determined resistance to serum bactericidal activity: a major outer membrane protein, the traT gene product, is responsible for plasmid-specified serum resistance in Escherichia coli.

Authors:  A Moll; P A Manning; K N Timmis
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

8.  Determinants that increase the serum resistance of Escherichia coli.

Authors:  P W Taylor; M K Robinson
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

9.  Characterization of complement resistance in Escherichia coli conferred by the antibiotic resistance plasmid R100.

Authors:  R T Ogata; R P Levine
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

10.  On the mechanism of cell membrane damage by complement: evidence on insertion of polypeptide chains from C8 and C9 into the lipid bilayer of erythrocytes.

Authors:  C H Hammer; M L Shin; A S Abramovitz; M M Mayer
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

View more
  23 in total

1.  Interaction of complement with serum-sensitive and serum-resistant strains of Pseudomonas aeruginosa.

Authors:  N L Schiller; K A Joiner
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

2.  Lipopolysaccharide phase variation determines the complement-mediated serum susceptibility of Coxiella burnetii.

Authors:  S Vishwanath; T Hackstadt
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

3.  Streptococcus pneumoniae phosphoglycerate kinase is a novel complement inhibitor affecting the membrane attack complex formation.

Authors:  Anna M Blom; Simone Bergmann; Marcus Fulde; Kristian Riesbeck; Vaibhav Agarwal
Journal:  J Biol Chem       Date:  2014-10-03       Impact factor: 5.157

Review 4.  Lipopolysaccharide O-antigens-bacterial glycans made to measure.

Authors:  Chris Whitfield; Danielle M Williams; Steven D Kelly
Journal:  J Biol Chem       Date:  2020-05-18       Impact factor: 5.157

5.  Protective role of magnesium in the neutralization by antibodies of Chlamydia trachomatis infectivity.

Authors:  E M Peterson; G M Zhong; E Carlson; L M de la Maza
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

6.  Multimeric complement component C9 is necessary for killing of Escherichia coli J5 by terminal attack complex C5b-9.

Authors:  K A Joiner; M A Schmetz; M E Sanders; T G Murray; C H Hammer; R Dourmashkin; M M Frank
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

7.  Comparative immunogenicity of conjugates composed of Escherichia coli O111 O-specific polysaccharide, prepared by treatment with acetic acid or hydrazine, bound to tetanus toxoid by two synthetic schemes.

Authors:  R K Gupta; W Egan; D A Bryla; J B Robbins; S C Szu
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

8.  Role of immunoglobulin G in killing of Borrelia burgdorferi by the classical complement pathway.

Authors:  S K Kochi; R C Johnson
Journal:  Infect Immun       Date:  1988-02       Impact factor: 3.441

9.  Effects of the combination of lipopolysaccharide-specific monoclonal antibodies and sparfloxacin against Pseudomonas aeruginosa pneumonia in neutropenic mice.

Authors:  K Oishi; F Sonoda; A Iwagaki; S Kobayashi; T Nagatake; K Matsumoto
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

10.  Characterization of a polysaccharide capsular antigen of septicemic Escherichia coli O115:K "V165" :F165 and evaluation of its role in pathogenicity.

Authors:  M Ngeleka; J Harel; M Jacques; J M Fairbrother
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.